retatrutide compound cost Best Peptide (Triple Agonist) GLP-3 Retatrutide (24mg vials) -

At 4mg, the phase 2 trial showed 17.1% average weight loss at 48 weeks, which exceeds the maximum dose of semaglutide (14.9%) in its own trial

But persistent cramps, especially nocturnal leg cramps or cramps that happen during light activity, strongly suggest magnesium or potassium deficiency

This summary provides basic information about Foundayo but does not include all information known about this medicine

(Wegovy, Zepbound, or Foundayo only) Pregnancy and breastfeeding - speak with your provider if you are or plan to be pregnant or breastfeeding, as these GLP-1 agonists should only be used during pregnancy or breastfeeding if the potential benefit outweighs potential risk to the fetus or breastfed infant